SpaceX Shares Fail to Launch Despite Soaring Revenue. Is the Stock a Buy on the Dip?

SpaceX’s Q2 results were strong—revenue +92% to $7.81B and net income improved to $541M (vs. a $1B loss)—but the stock faces downside risk from heavy capex and upcoming share lock-up expirations. The quarter’s AI capex jumped from $749M to $15.8B, while free cash flow was deeply negative at -$25B over the first six months after $28.5B in capex. Despite $100B in cash raised at IPO, the article flags a ~40x forward P/S valuation and the likelihood of continued dilution as new supply hits the market, keeping near-term downside bias.

Analysis

SPCX looks like a classic late-stage growth stock where the first-order earnings beat is less important than the financing path. The combination of heavy capex, a still-rich sales multiple, and coming secondary supply raises the probability of multiple compression before any incremental operating leverage shows up; that risk is most acute over the next 1-3 months around lock-up windows and any employee/early holder monetization.

The clearest relative winner is NVDA, but only at the margin: if SPCX keeps buying premium chips and cloud overflow, it supports demand at the high end of the AI stack. The bigger second-order effect is negative for other capital-intensive growth names, because a visible willingness to burn cash can reset investor tolerance for "expansion first, profits later" stories across private AI and space-adjacent comps.

The contrarian miss is that the market may be underestimating how quickly enthusiasm fades once the story shifts from product velocity to capital intensity. What would falsify the short thesis is a clean quarter where lock-up supply is absorbed, capex intensity falls, and management credibly narrows the gap between revenue growth and free cash flow burn; absent that, downside should remain skewed to the next 6-18 months. This is more of a valuation/supply overhang than an immediate fundamental collapse, so timing matters more than conviction alone.

Key Decisions for Investors

• If liquid, initiate a tactical short SPCX into lock-up expiry windows over the next 2-8 weeks; target a 15-25% downside move on multiple compression, with a cover trigger if post-lock-up volume is absorbed and the stock reclaims its post-IPO range.
• Use NVDA as a small hedge, not a core long: pair long NVDA / short SPCX only if you want exposure to the chip demand spillover while isolating the valuation and dilution risk in SPCX; best on any strength in NVDA after AI-supply chain headlines.
• Avoid chasing other pre-profit, capex-heavy private growth names for the next quarter; if a listed peer basket is available, treat SPCX weakness as a warning signal for broad multiple compression in late-stage AI/space names.
• Set an alert for any SPCX update on capex guidance or secondary issuance: if free cash flow stays deeply negative while capex rises, the next catalyst is likely a financing event, which would be the most durable bearish trigger.